Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
Acadia Healthcare (Nasdaq: ACHC), a national leader in behavioral health services, is accelerating its 2024 growth strategy with the acquisition of three new opioid...
At evolvedMD, we’re proud to celebrate the incredible achievements of our very own Kristy Geiszler, Clinical Manager, who has been named a 2023 Frontline...
Regal Healthcare Capital Partners, a private equity firm specializing in behavioral health investments, has committed $50 million in funding to Lightfully Behavioral Health, a...
Mental health care in the U.S. is undergoing a profound transformation. The growing demand for services, compounded by a shift in attitudes toward mental...
After several years of rapid growth, behavioral health dealmaking slowed down in 2023—but not across the board. While most segments saw a sharp drop...
Acadia Healthcare (Nasdaq: ACHC), the nation’s largest standalone behavioral health company, continues to pursue an aggressive growth strategy under the leadership of CEO Chris...